On this page
Kennedy disease (SBMA)
This condition gradually leads to muscle weakness and wasting, particularly in the limbs and face. It predominantly affects males, with symptoms typically appearing in adulthood.
Available at Jeen Health
Clinical tests that include this
Overview
Kennedy disease, formally known as spinal and bulbar muscular atrophy (SBMA), is a progressive neuromuscular disorder that impacts motor neurons, the nerve cells that control voluntary muscle movement [PMID:33675841]. It is a rare condition, predominantly affecting males. The disorder is characterised by muscle weakness and wasting, which worsen over time. While the primary impact is on muscle function, Kennedy disease can also affect other body systems due to its underlying genetic cause.
Symptoms typically begin in adulthood, generally between the ages of 30 and 50, though onset can vary [PMID:33675841]. The condition is named after William R. Kennedy, who first described it. Despite its progressive nature, individuals with Kennedy disease generally have a normal life expectancy, although their quality of life can be significantly impacted by the physical challenges.
Symptoms & clinical features
The initial symptoms of Kennedy disease often include muscle cramps and weakness. This weakness usually starts in the muscles closest to the body's centre, such as those in the shoulders and hips, leading to difficulty with activities like walking, climbing stairs, or lifting objects. As the condition progresses, muscle wasting (atrophy) becomes noticeable, particularly in the limbs.
Another characteristic feature involves the 'bulbar' muscles, which are those in the face, mouth, and throat. This can lead to difficulties with speech (dysarthria), swallowing (dysphagia), and chewing. Some individuals may also experience tremors, particularly in their hands, and muscle twitching (fasciculations). Non-muscular symptoms can include breast enlargement in males (gynaecomastia) and reduced fertility, related to the underlying hormonal impact of the condition [PMID:31258673].
Video: Genetics 101
Affected organs
Kennedy disease primarily affects the motor neurons in the brainstem and spinal cord, which are crucial for transmitting signals from the brain to the muscles. This leads to the characteristic muscle weakness and atrophy observed throughout the body, particularly in the limb and bulbar muscles. The condition also impacts the sensitivity to male hormones (androgens) due to the affected gene.
Consequently, other systems can be indirectly affected. For instance, the endocrine system might show changes, leading to hormonal imbalances that contribute to symptoms like gynaecomastia and testicular atrophy in males. In some cases, sensory nerves can also be mildly affected, leading to reduced sensation or nerve pain.
Risks & severity
Kennedy disease is a slowly progressive condition. The severity and rate of progression can vary between individuals, even within the same family. While the disease leads to increasing muscle weakness and disability over time, it is generally not life-threatening, and most individuals maintain a normal life expectancy.
Symptoms typically begin in mid-adulthood, often between 30 and 50 years of age. Over time, mobility may become significantly impaired, and some individuals may eventually require walking aids or wheelchairs. Difficulties with swallowing can increase the risk of aspiration (food or liquid entering the lungs), which can lead to lung infections. However, with appropriate management and supportive care, many complications can be mitigated.
Genetic causes
Kennedy disease is caused by a genetic change in the AR gene. This gene provides instructions for making the androgen receptor protein. The androgen receptor is essential for the body's response to male hormones, known as androgens, such as testosterone. It plays a critical role in the development of male sexual characteristics both before and after birth, and in regulating various bodily functions in both males and females.
In Kennedy disease, the AR gene contains an expanded section of DNA. This expansion leads to the production of an altered, faulty androgen receptor protein. The abnormal protein is thought to become toxic to motor neurons, gradually causing their degeneration. This progressive loss of motor neurons is what leads to the muscle weakness and wasting characteristic of the condition.
- AR androgen receptorThe AR gene provides instructions for the androgen receptor protein, which is vital for male sexual development and other functions in both sexes by responding to hormones like testosterone.
Inheritance pattern
Kennedy disease follows an X-linked recessive inheritance pattern. This means the AR gene is located on the X chromosome, one of the two sex chromosomes.
Males (who have one X and one Y chromosome) are predominantly affected because they only have one copy of the X chromosome. If their single X chromosome carries the altered AR gene, they will develop the condition. Females (who have two X chromosomes) can be carriers if one of their X chromosomes has the altered gene, while the other X chromosome has a working copy. Female carriers usually do not develop the full symptoms of Kennedy disease, or they may experience milder symptoms later in life, because their unaffected X chromosome can compensate. Each son of a female carrier has a 50% chance of inheriting the altered gene and developing the condition, while each daughter has a 50% chance of being a carrier.
X-linked recessive: sons of a carrier mother have a 50% chance of being affected. Daughters have a 50% chance of being carriers.
Diagnosis & testing
The diagnosis of Kennedy disease often begins with a clinical suspicion based on the characteristic symptoms, such as progressive muscle weakness, speech and swallowing difficulties, and sometimes hormonal signs like gynaecomastia. A neurologist will typically conduct a physical examination and may perform nerve conduction studies and electromyography (EMG) to assess nerve and muscle function.
A definitive diagnosis is confirmed through genetic testing. This involves a blood test to look for the specific expansion in the AR gene. In the UK, genetic testing for Kennedy disease is available through the NHS Genomic Medicine Service. Your specialist may refer you to a clinical genetics service, which can arrange the appropriate testing. The relevant R-code for diagnostic testing would typically fall under neuromuscular conditions.
Management & lifestyle
While there is currently no cure for Kennedy disease, management focuses on alleviating symptoms and improving quality of life. A multidisciplinary team, which may include neurologists, physiotherapists, occupational therapists, speech and language therapists, and endocrinologists, often provides care.
Physiotherapy and occupational therapy can help maintain muscle strength and flexibility, improve mobility, and suggest adaptive equipment to assist with daily activities. Speech and language therapy can help manage difficulties with speech and swallowing, potentially reducing the risk of aspiration. Hormonal therapies are sometimes considered for symptoms like gynaecomastia, but their impact on disease progression is still under investigation [PMID:31258673]. Regular monitoring by a specialist team is important to address emerging symptoms and complications.
UK care pathway
In the UK, individuals suspected of having Kennedy disease would typically be referred by their GP to a neurologist for specialist assessment. If Kennedy disease is suspected, a referral to a clinical genetics service would then be made for genetic counselling and testing. Genetic testing for neuromuscular conditions like Kennedy disease is available through the NHS Genomic Medicine Service. A genetic counsellor can provide detailed information about the condition, its inheritance pattern, and implications for family members.
Frequently asked questions
Is Kennedy disease only found in males?
Kennedy disease primarily affects males because it is an X-linked recessive condition. Females can be carriers of the gene change, and while they usually do not develop the full condition, some may experience milder symptoms later in life, such as muscle cramps or weakness.
What is the life expectancy for someone with Kennedy disease?
Individuals with Kennedy disease generally have a normal life expectancy. While the condition is progressive and can lead to significant physical disability, it is typically not life-threatening. Management focuses on supporting quality of life and managing symptoms.
Can Kennedy disease be passed on to children?
Yes, Kennedy disease is an inherited condition. If a male with Kennedy disease has children, all his daughters will be carriers, and none of his sons will inherit the condition. If a female carrier has children, each child has a 50% chance of inheriting the altered gene. Sons who inherit it will develop the condition, and daughters who inherit it will be carriers.
Are there any treatments to stop the progression of Kennedy disease?
Currently, there is no treatment that can stop or reverse the progression of Kennedy disease. Management focuses on supportive care, such as physiotherapy, occupational therapy, and speech therapy, to help manage symptoms and maintain function. Research is ongoing into potential new therapies.
How rare is Kennedy disease?
Kennedy disease is considered a rare condition, affecting approximately 1 in 40,000 males. Due to its rarity, it can sometimes take time to receive a diagnosis.